Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management
Journal of Pain Research · 2026-09 · Volume 19 · 1-14
DOI: 10.2147/jpr.s637884 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pain Research, 2026-09. Verfasst von Hajar Haghshenas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, School of Nursing, Gerash University of Medical Sciences, Gerash, Iran. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, School of Nursing, Gerash University of Medical Sciences, Gerash, Iran.
- Student Research Committee, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.
- Community Based Psychiatric Care Research Center, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Maryam Shaygan
Zitieren
APA
Haghshenas, H., Shaygan, M., Pasyar, N., & Rambod, M. (2026). Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management. Journal of Pain Research, Volume 19, 1-14. https://doi.org/10.2147/jpr.s637884
Vancouver
Haghshenas H, Shaygan M, Pasyar N, Rambod M. Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management. Journal of Pain Research. 2026;Volume 19:1-14. doi:10.2147/jpr.s637884
BibTeX
@article{Haghshenas2026,
author = {Haghshenas, Hajar and Shaygan, Maryam and Pasyar, Nilofar and Rambod, Masoume},
title = {Strengthening Pain Resilience Through Mobile Technology: A Randomized Controlled Trial on Pain Intensity and Disability in Chronic Pain Management},
journal = {Journal of Pain Research},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/jpr.s637884}
}
EUVIMED